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Abstract
 
In 
 
Plasmodium falciparum
 
–endemic areas, pregnancy-associated malaria (PAM) is an important
health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes
(IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens
(VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA
types, VSA
 
PAM
 
, which can be serologically classified as sex specific and parity dependent. It is
sex specific because men from malaria-endemic areas do not develop VSA
 
PAM
 
 antibodies; it is
parity dependent because women acquire anti-VSA
 
PAM
 
 immunoglobulin (Ig) G as a function of
parity. Previously, it was shown that transcription of 
 
var2csa
 
 is up-regulated in placental para-
sites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA
is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic
plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels
can be found in pregnant women from both West and East Africa; and (d) that women with
high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a
much lower risk of delivering low birth weight children than women with low levels.
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Introduction
 
Individuals living in areas of intense 
 
Plasmodium falciparum
 
transmission have acquired protective immunity to malaria
by the time they reach sexual maturity. Pregnant women
constitute an important exception to this rule, and pregnancy-
associated malaria (PAM) is an important cause of maternal
and perinatal morbidity and mortality in such areas (1).
PAM is characterized by placental accumulation of parasite-
infected erythrocytes (IEs), which are unusual in being able
to bind to chondroitin sulfate A (CSA) in vitro (2) and in
not being recognized by IgG in the plasma of malaria-exposed
men who have IgG with specificity for IEs infecting non-
pregnant individuals (3, 4).
These data suggest that the variant surface antigens (VSAs)
responsible for placental adhesion to CSA are not only func-
tionally and antigenically distinct from other molecules present
at the iRBC surface, but also that they share relatively con-
served antigenic determinants (2, 3, 5). Specific acquired
immunity to PAM increases with increasing parity (3–5)
and is mediated by IgG with specificity for PAM-type VSA
(VSA
 
PAM
 
; 6, 7). Parasites that express VSA
 
PAM
 
-type antigens
on the IE surface selectively transcribe an unusually structured
 
var
 
 gene (
 
var2csa
 
) at high levels (8), but the presence of a short
open reading frame upstream of the 
 
var2csa
 
 initiation codon (9,
10) has raised concern that 
 
var2csa
 
 mRNA may not be trans-
lated into protein despite high transcription rates (11). Here,
we present evidence that VAR2CSA, which is a relatively
conserved (8) member of the 
 
P. falciparum
 
 erythrocyte mem-
brane protein 1 (PfEMP1) family (12) is expressed on the sur-
face of CSA-selected IEs and that plasma levels of VAR2CSA-
specific IgG correlate with protection from PAM.
 
Materials and Methods
 
Recombinant Proteins.
 
A synthetic 
 
var2csa
 
 gene based on the
 
P. falciparum
 
 clone 3D7 sequence (PlasmoDB accession no.
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PFL0030c) was generated and optimized for codon usage by 
 
Tri-
choplusia ni
 
 insect cell lines. Repeats, poly-A sites, and instability
elements were removed without altering the protein sequence
(Geneart). Domains of the synthetic 
 
var2csa
 
 gene were cloned
into the pBAD-TOPO vector (Invitrogen) by PCR using the
following primers: DBL1-X, Fw: 5
 
 
 
-CGGAATTCATGGACA-
AGTCCTCCATC-3
 
 
 
, DBL1-X, Rv: 5
 
 
 
-GATGCAGGTCTT-
GTTGCT-3
 
 
 
; and DBL5-
 
 
 
, Fw: 5
 
 
 
-CGGAATTCCTGGACA-
GATGCTTCGAC-3
 
 
 
, and DBL5-
 
 
 
, Rv: 5
 
 
 
-CTTGTTGCAG-
ATGTAGTC-3
 
 
 
. An exon 2 construct and the DBL5-
 
 
 
 domain
of 
 
var4
 
 gene were cloned (13). Recombinant proteins based on
these constructs were produced in 
 
Baculovirus
 
-infected Sf9 cells
and purified (13).
 
Animal Antisera.
 
Antisera were raised by injection of 20 
 
 
 
g of
recombinant proteins (s.c.) into rabbits in Freund’s complete adju-
vant, followed by four booster injections of 20 
 
 
 
g of protein in Fre-
und’s incomplete adjuvant at 3-wk intervals. Antisera were collected
15 d after the final booster injection. The total amount of IgG in the
rabbit sera was measured using a rabbit serum IgG ELISA kit.
 
Human Plasma Samples.
 
Three panels of plasma samples from
Ghanaian individuals exposed to hyperendemic and seasonal 
 
P.
falciparum
 
 transmission were used. Ethical clearance was granted
by the Ministry of Health, Ghana. The first panel was collected
from 39 men and 46 women, the second was from 30 men and
27 term-pregnant women, and the third was obtained at the time
of delivery from 62 pregnant women of different parities. To an-
alyze the relationship between IgG reactivity and recombinant
proteins and birth weight of offspring, we used a plasma sample
set obtained at the time of delivery from 110 Kenyan women
with histological evidence of active-chronic placental 
 
P. falci-
parum
 
 infection (14). Ethical clearance was granted by the Kenyan
Medical Research Institute National Ethical Review Committee.
Plasma samples from six adults without 
 
P. falciparum
 
 exposure
were used as negative controls.
 
Malaria Parasites and In Vitro Selection Procedures.
 
All 
 
P. falci-
parum
 
 lines used were maintained in culture (15). Selection for
expression of VSA
 
PAM
 
-type antigens on the IE surface was
achieved by repeated panning of IEs on CSA in vitro (3, 4). Se-
lection for expression VAR2CSA was achieved by repeated pan-
ning of IEs using IgG-reactive DynaBeads VAR2CSA DBL5-
 
 
 
–
specific antisera (15).
 
Measurement of var2csa-specific Antibody Levels in Plasma.
 
Plasma
levels of 
 
P. falciparum
 
 antigen-specific IgG were measured in stan-
dard ELISA assays (16). Cut-off values were set to mean plus two
standard deviations of readings obtained with the negative control
plasma samples.
 
Measurement of var2csa-specific, IE Surface-reactive Antibodies.
 
IgG
reactivity to antigens expressed on the surface of intact 
 
P. falci-
parum
 
–infected erythrocytes were evaluated by flow cytometry
and confocal microscopy. Analysis by flow cytometry was per-
formed as described (13), except for the sequential usage of 4 
 
 
 
l
of goat anti–rabbit IgG (401311; Calbiochem), 4 
 
 
 
l of biotinyl-
ated rabbit anti–goat Ig (DakoCytomation), and 0.5 
 
 
 
l of FITC-
conjugated streptavidin (BD Biosciences) for detection of rabbit
IgG on the IE surface. Confocal microscopy was done on an
LSM5 scanning microscope (Carl Zeiss MicroImaging, Inc.) us-
ing wet-mounted antibody-labeled IEs.
 
Statistical Analysis.
 
Sex specificity of IgG levels was evaluated
by Mann-Whitney rank sum test (T), whereas parity dependency
was evaluated by Spearman’s rank correlation coefficient (rs).
Stata v. 7 (Stata Corporation), SigmaStat v. 3.0 (SPSS), and CIA
v. 2.0 software were used.
 
Results and Discussion
 
P. falciparum
 
 parasites implicated in PAM express a sero-
logically defined VSA subset (VSA
 
PAM
 
) on the IE surface.
VSA
 
PAM
 
 are not recognized by IgG in the plasma of ma-
laria-exposed men (sex specificity), and levels of VSA
 
PAM
 
-
specific IgG in the plasma of women depend on their num-
ber of pregnancies (parity dependency; references 3–5). To
investigate whether 
 
var2csa
 
-encoded proteins (VAR2CSA)
are expressed on the surface of such IEs, we determined the
IE surface reactivity of antisera raised against recombinant
proteins corresponding to two 
 
var2csa
 
 domains.
We found that IgG in rabbit antisera raised against
DBL5-
 
 
 
 domain of VAR2CSA specifically labeled the
surface of erythrocytes infected by two VSA
 
PAM
 
-express-
ing parasite lines (Fig. 1, a and c). Furthermore, examina-
tion of IEs by confocal microscopy showed a punctate sur-
face labeling characteristic of PfEMP1 surface localization
(Fig. 1, e, g, and i). VAR2CSA-specific antisera did not la-
bel erythrocytes infected by isogenic parasite lines not ex-
pressing VSA
 
PAM
 
 (Fig. 1, b, d, f, and h). Experiments using
antisera raised against DBL1-X gave identical results (un-
published data). VSA
 
PAM
 
-expressing IEs have previously
been shown to have a generally increased reactivity with
IgG and IgM (17, 18). Therefore, we tested control rabbit
antisera containing the same amount of total IgG and
raised against a surface-exposed domain (DBL5-
 
 
 
) of a
PfEMP1 associated with severe 
 
P. falciparum
 
 malaria in
children (VAR4; references 13, 15). Neither VAR4-spe-
cific antiserum (Fig. 1, a–d) nor rabbit prebleed control se-
rum (not depicted) reacted with the surface of intact
erythrocytes infected by any of the aforementioned para-
site lines. The double peak in the flow diagram of anti-
VAR2CSA–labeled CSA-selected NF54 (Figs. 1 a and 2 a)
indicated that approximately half of these parasites ex-
pressed VAR2CSA, suggesting that the remaining parasites
expressed other VSA
 
PAM
 
 than VAR2CSA or that some of
the parasites had changed VSA expression since CSA se-
lection. To investigate this, we selected the NF54CSA iso-
late on VAR2CSA antibodies using IgG-reactive Dyna-
Beads and obtained a parasite line in which a markedly
larger proportion of the IEs reacted with VAR2CSA IgG
(Fig. 2, a and b). After IgG selection, the parasites were
also better recognized by plasma from term-pregnant women
and mostly unrecognized by plasma from sympatric men
(Fig. 2, c and d).
 
Figure 1.
 
Analysis by flow cytometry (a–d) and confocal microscopy (e–h) of intact erythrocytes infected by 
 
P. falciparum
 
 line NF54 (a, b, e, f, and i) or
FCR3 (c, d, g, and h) and labeled by IgG in rabbit antisera raised against VAR2CSA DBL5-
 
 
 
 (a–d, solid red, and e–h) or VAR4 DBL5-
 
 
 
 (a–d, solid
gray) as a control serum. Infected erythrocytes subjected to several rounds of in vitro selection for adhesion to CSA (a, c, e, g, and i) or unselected (b, d,
f, and h) are shown. Confocal microscopy images (e–h) were unstained (left), stained with ethidium bromide and labeled by anti-VAR2CSA IgG (middle),
or stained by anti-VAR2CSA IgG only. Confocal panel i shows the double stained parasites. The left image (red) is IgG staining with pooled plasma from
pregnant women; the middle image (green) is stained with anti-VAR2CSA IgG; and the right image is an overlay of the two first images. The staining of
the central spot in the confocal images without EtBr is caused by autofluorescence of hemozoin. 
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To investigate the relationship between VAR2CSA and
VSA
 
PAM
 
 further, we used flow cytometry to analyze IEs
double labeled with an antiserum to VAR2CSA DBL5-
 
 
 
and plasma pools from 
 
P. falciparum
 
–exposed men and
pregnant women, respectively. VSA
 
PAM
 
-expressing, CSA-
selected IEs appeared as a double positive population (Fig.
3 a) when using the pool from pregnant women, but as a
single (VAR2CSA DBL5-
 
 
 
) positive population when us-
ing the male pool (Fig. 3 b). In contrast, unselected IEs ex-
pressing non-PAM–type VSA were not labeled by the
DBL5-
 
 
 
 antiserum and were recognized to a similar degree
by the plasma pools from men and pregnant women (Fig.
3, c and d). Examination of IEs by confocal microscopy
showed that the targets of IgG in the DBL5-
 
 
 
 antiserum
and the pooled plasma from pregnant women colocalized
on the IEs surface (Fig. 1 i). Together, these results suggest
that VAR2CSA is selectively expressed on the surface of
IEs that have been selected for adhesion to CSA in vitro
and that have a sex-specific and parity-dependent VSA
 
PAM
 
-
type IgG recognition profile. The data also indicate that the
targets of the VAR2CSA-specific and VSA
 
PAM
 
-specific IgG
are identical or closely associated.
To examine whether human IgG recognition of VAR2-
CSA depended on plasma donor sex and parity, we used
ELISA to measure levels of VAR2CSA-specific IgG in
panels of individual plasma samples from 
 
P. falciparum
 
–
exposed men and women. Median levels of IgG specific for
recombinant proteins corresponding to the DBL1-X and
DBL5-
 
 
 
 domains of VAR2CSA were significantly different
(DBL1-X: P 
 
  
 
0.001 [T], median difference [95% CI] 
 
 
 
0.10 [0.054–0.20]; DBL5-
 
 
 
: P 
 
  
 
0.001 [T], median differ-
ence [95% CI] 
 
 
 
 0.14 [0.081–0.27]) in plasma from
women than in plasma from men (Fig. 4 a). This pattern
was even more pronounced when examining samples from
a separate cohort of sympatric men and term-pregnant
women (DBL1-X: P 
 
  
 
0.001 [T], median difference [95%
CI] 
 
  
 
2.13 [1.54–2.45]; DBL5-
 
 
 
: P 
 
  
 
0.001 [T], median
difference [95% CI] 
 
 
 
 2.34 [1.46–2.59]; Fig. 4 b). Nega-
tive control plasma from donors without 
 
P. falciparum
 
 ex-
posure did not contain VAR2CSA-specific IgG (unpub-
lished data).
To exclude that the differences in VAR2CSA-specific
IgG reactivity were simply due to a generally increased 
 
P.
falciparum
 
–specific IgG reactivity among the women, we
also measured levels of IgG specificity for another, non-
PAM–type PfEMP1 (VAR4; reference 13) and the non-
PfEMP1 antigen, GLURP (16). We did not observe any
significant sex-specific differences in the IgG levels for ei-
ther of these antigens (VAR4 DBL5- : P   0.096 [T], me-
dian difference [95% CI]    0.047 [ 0.22–0.16] [Fig. 4
a]; P   0.78 [T], median difference [95% CI]   0.00
[ 0.18–0.13]; Fig. 4 b) or GLURP (P   0.39 [T], median
difference [95% CI]    0.11 [ 0.46–0.16] and P   0.23
[T], median difference [95% CI]   0.27 [ 0.14–0.91]; Fig.
4 c). In addition to the sex specificity of VAR2CSA-spe-
cific IgG levels, we observed that these levels also depended
on donor parity in individual plasma samples from term-
pregnant women with parities ranging from 0 to 10 (rs  
0.38, P   0.0027; Fig. 4 d). This correlation remained sig-
nificant in a linear regression model, including both parity
and age as explanatory variables (P   0.03). In contrast,
GLURP-specific IgG levels did not depend significantly on
parity (P   0.94; unpublished data).
Plasma levels of VSAPAM-specific IgG correlate with ac-
quisition of protective immunity to PAM; in fact, there is
strong recent evidence to suggest a causal relationship between
Figure 2. Flow cytometry analyses of intact infected
erythrocytes (a and b) labeled by IgG against
VAR2CSA DBL5-  (solid red) and VAR4 DBL5- 
(solid gray). Erythrocytes were infected with CSA-
selected NF54 (a) or a subline of this parasite, which
had been subjected to additional in vitro selection for
binding to VAR2CSA DBL5- –specific IgG (b). (c
and d) The recognition of the two parasite lines by
plasma IgG from 10 Ghanaian term-pregnant women
(pFb), 10 sympatric Ghanaian men (Mb), and 10 Dan-
ish controls (DK). For each group, the median (central
line), the central 50% (box), the central 80% (bars), and
the central 90% (•) of data points are shown.Salanti et al. Brief Definitive Report 1201
high levels of VSAPAM-specific antibodies and protection
from maternal anemia, low birth weight, and prematurity
due to PAM (6, 7). Adverse PAM-related pregnancy out-
comes are concentrated among women with an ongoing
placental infection of sufficient duration to allow detection
of both IEs and hemozoin-laden phagocytes in the placenta
at the time of delivery (active-chronic–type PAM; refer-
ence 14), and it is also among women with active-chronic
PAM that the protective effect of VSAPAM-specific IgG is
most readily detected (7).
To investigate whether a similar relationship exists be-
tween levels of IgG specific for VAR2CSA and birth
weight of offspring, we studied the relationship between
pregnancy outcome and VAR2CSA-specific plasma IgG
levels at the time of delivery in a group of P. falciparum–
exposed women participating in a study of the impact of
PAM on pregnancy outcome. The samples studied here
belonged to the random subset of the original cohort used
to study the relationship between VSAPAM-specific IgG
levels and pregnancy outcome (7), and included all the 110
women in that subset who were found to suffer from ac-
tive-chronic PAM. Logistic regression analysis showed that
high (i.e., above median) plasma levels of VAR2CSA
DBL5- –specific plasma IgG were associated with a four-
fold lower risk of giving birth to a seriously underweight
( 2.500 g) infant (Table I). Correspondingly, women with
high (i.e., above median) plasma levels of VAR2CSA DBL5-
 –specific plasma IgG delivered babies weighing 2.864 g
(95% CI: 2.700–3.029 g) compared with 2.436 g (95% CI:
2.264–2.608 g) for women with low (i.e., below median)
VAR2CSA DBL5- –specific plasma IgG levels.
We have shown previously that the var2csa gene is re-
markably conserved between parasite isolates (8). Here, we
show that 3D7 VAR2CSA-specific antisera labeled different
CSA-selected parasite lines (Fig. 1), and that 3D7 VAR2-
CSA-specific IgG could be detected in plasma from preg-
nant women from both West and East Africa (Figs. 2–4).
Together, these findings indicate substantial serological
cross-reactivity between VAR2CSA from different parasites.
The fact that levels of VAR2CSA-specific IgG correlated
with sex and parity in plasma from P. falciparum–exposed in-
dividuals (a characteristic shared with the VSAPAM-specific
IgG mediating protection against adverse pregnancy out-
come due to placental P. falciparum infection; Fig. 4 and ref-
erences 6, 7) is consistent with the paradigm that PAM de-
velops in otherwise malaria-immune women when they are
infected with parasites that rely on placental binding to CSA
for survival and that express IE surface antigens to which the
women do not have specific protective immunity.
Several groups have identified CSA-binding domains in
PfEMP1 molecules (19-21). The most extensively studied of
these genes (var1csa) does not show enhanced transcription in
Figure 3. Colabeling of intact
erythrocytes infected by P. falci-
parum line FCR3 by IgG in rabbit
antisera raised against VAR2CSA
DBL5-  and by plasma pools
from P. falciparum–exposed, term-
pregnant women (a and c) or
from sympatric men (b and d).
Infected erythrocytes subjected
to several rounds of in vitro se-
lection for adhesion to CSA (a
and b) or without pretreatment
(c and d) are shown.VAR2CSA and Protection from Pregnancy-associated Malaria 1202
placental or CSA-selected parasites (22, 23) and is transcribed
by parasites from nonpregnant females and children (24, 25).
Although antibodies against VAR1CSA constructs have
been reported to react selectively with the surface of placen-
tal and CSA-selected isolates (26, 27), the role of nonspecific
IgG and IgM binding to placental and CSA-selected isolates
(17, 18) and the impact of selection on Saimiri brain endo-
thelial cells used in these experiments (28, 29) have only
been partially resolved. Furthermore, sex-specific and parity-
dependent plasma IgG recognition of IEs after Saimiri brain
endothelial cell selection has not been reported, but domains
from VAR1CSA do not show the expected VSAPAM-type
sex-specific and parity-dependent IgG recognition (30). There-
fore, the presence of CSA-binding domains that can be in-
hibited by specific IgG or CSA in itself is not sufficient evi-
dence for involvement in the pathogenesis of PAM (29).
In conclusion, we find that IEs with the VSAPAM pheno-
type implicated in PAM selectively express VAR2CSA and
that high VAR2CSA-specific IgG levels are related to fa-
vorable birth outcome. This raises hope that VAR2CSA-
specific IgG induced by vaccination of women in malaria-
endemic areas before their first pregnancy can protect
against adverse consequences of malaria in pregnancy.
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